DIN 02509474 — AJOVY 225 MG
AJOVY is a solution of Fremanezumab marketed by TEVA CANADA LIMITED. The full Fremanezumab monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02509474
- Brand name
- AJOVY
- Active ingredient
- Fremanezumab
- Strength
- 225 MG
- Dosage form
- SOLUTION
- Route
- SUBCUTANEOUS
- Manufacturer
- TEVA CANADA LIMITED
- Health Canada status
- MARKETED
- Drug class
- Calcitonin gene-related peptide (CGRP) antagonist (monoclonal antibody)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Fremanezumab products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02497859 | AJOVY | 225 MG | SOLUTION | TEVA CANADA LIMITED | MARKETED |